Aster DM Healthcare has fixed July 9, 2026, as the record date to determine the eligibility of Quality Care India Limited shareholders for the allotment of equity shares pursuant to the Scheme of Amalgamation. The Board of Directors approved this date during its meeting held on June 25, 2026, following the National Company Law Tribunal (NCLT), Hyderabad Bench, order dated June 19, 2026. The scheme facilitates the merger of Quality Care India Limited with Aster DM Healthcare Limited.

The share exchange ratio for the amalgamation is set at 977 fully paid-up equity shares of Aster DM Healthcare Limited, each with a face value of INR 10, for every 1,000 equity shares held in Quality Care India Limited. The entitlement of shareholders will be determined based on their holdings on the record date. The NCLT approved the scheme under Sections 230 to 232 of the Companies Act, 2013.

Key Details of the Amalgamation

The following table outlines the primary entities and the specific terms of the scheme:

The Scheme of Amalgamation will become effective only after the respective companies file the certified copy of the NCLT order with the Registrar of Companies and satisfy other conditionalities mentioned in the scheme. Upon the scheme becoming effective, Quality Care India Limited shall stand dissolved without winding up. Aster DM Healthcare Limited will inform the stock exchanges about the Effective Date of the scheme in due course. The intimation was submitted to the BSE Limited and the National Stock Exchange of India Ltd in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, a subsidiary of aster dm healthcare , has allotted 46,30,000 Compulsorily Convertible Preference Shares (CCPS) to identified investors on a preferential basis by way of private placement. The allotment was approved by the subsidiary's board on June 23, 2026, pursuant to Regulation 30(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The issuance comprises both fully paid-up and partly paid-up shares, with a conversion ratio of up to 5 equity shares for each CCPS.

Breakdown of Allotment

The board allotted two distinct series of CCPS. Series A shares are fully paid-up, while Series B shares are partly paid-up. Both series carry a face value of Rs. 50 each.

Conversion and Shareholding Structure

The CCPS issued will convert into equity shares of the subsidiary. As on the date of allotment, the conversion ratio stipulates that each CCPS shall convert into a maximum of up to 5 equity shares. This conversion mechanism will dilute the shareholding of existing stakeholders, subject to the terms approved by the subsidiary's shareholders.

Aster DM Healthcare disclosed that its shareholding in the subsidiary will not go below 75% of the share capital on an as-if converted basis. This threshold accounts for the conversion of the allotted Series A CCPS, Series B CCPS, and any Additional Investment that the subsidiary may finalize in the future.

Future Capital Raising Plans

The subsidiary is actively pursuing further capital infusion. It is in the process of finalizing other investors to whom certain other CCPS may be issued in due course. This prospective issuance is referred to as Additional Investment. The company confirmed that the 75% minimum shareholding commitment for Aster DM Healthcare remains valid even after this Additional Investment is accounted for.

The filing was submitted by Hemish Purushottam, Company Secretary and Compliance Officer of Aster DM Healthcare Limited.